New York Republican Rep. Chris Collins was arrested and indicted on charges related to securities fraud Wednesday.

The indictment is tied to securities of an Australian biotechnology company, Innate Immunotherapeutics where Collins has served on the board of directors.

Collins’ latest sale of Innate Immunotherapeutics holdings was on June 20, 2018 and valued between $15,000 and $50,000 according to House periodic transaction reports. He bought at least 4 million shares between 2016 and 2018, according to the reports. Collins’ value in Innate went from $25,000,001 to $1,000,001, according to his most recent financial disclosure. He serves on the Health subcommittee of House Energy and Commerce.

Last August, the House Ethics Committee took up an inquiry into Collins and allegations that he had shared nonpublic information about the company, in violation of House rules, standards of conduct, and federal law.

Watch: Mr. Hawkings’ Opus – 5 Reasons Why Congress Is Broken